These cells give rise to differentiated-type HNSCC tumors consisting of CD44vhigh undifferentiated tumor cells and CD44vlow-neg/involucrin+ differentiated tumor cells in vivo (Figure 4A), as we previously described [16]. The gene discussed is IVL; the disease is neoplasm.